Peptides Lack Reliable Safety Information, Watchdog Warns FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. BPC 157: Experimental Peptide Creates Risk for Athletes